Clinical trial

Phentermine/Topiramate for Uric Acid Stones

NCT04621929

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-31

PhasePHASE2

Study timeline

Study start (actual)2021-03-31Date precision: day

Registry last updated2026-06-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Uric Acid Stonesunresolved

Type 2 Diabetes Mellitus in Obeseunresolved

Pre-Diabetesunresolved

Interventions

Phentermine / Topiramate Oral ProductDRUG

Citrate Salts, Allopurinol, DietCOMBINATION_PRODUCT

Sponsors & collaborators

University of Floridalead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

GainesvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04621929 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.